Not a single study
Story checked
Nasal vaccine additive improves flu survival in mice even 100 days after treatment (opens in a new tab)
medicalxpress.com · 2026-10-09
Short answer
Not a single studyNo clear answer.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Nasal vaccine additive improves flu survival in mice even 100 days after treatment
medicalxpress.com · 2026-10-09
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
This story isn't reporting one study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Open claim evidenceSearch result
No single source study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Also referencedpresented as the new finding
Long-term Immunoprophylaxis by TLR9 Ligand Mediates Macrophage-ILC Crosstalk Against Respiratory Viral Infection
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedA research team led by Ken Ishii investigated how the vaccine adjuvant K3-SPG modulates innate immunity, and the study was published in Science Advances.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedA single intranasal dose of K3-SPG protected mice against influenza A virus: treated mice lost less weight and had higher survival rates than control mice, with protection still detectable 100 days after treatment.View evidenceHide evidence
As stated100 days after treatment
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedThe nasal route produced stronger protection than giving the treatment under the skin or into the bloodstream.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedK3-SPG also protected mice against SARS-CoV-2 in a susceptible mouse model.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedDespite improving survival and reducing lung damage, K3-SPG did not substantially reduce the amount of virus in the lungs, suggesting it mainly improved disease tolerance rather than directly blocking viral replication.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedThe protection appeared to involve a two-stage innate immune response, with macrophages important early and innate lymphoid cells important later, and the response depended on TLR9 and TNF-α.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
Crossref, PubMed, Europe PMC · 35 candidate papers
Author response for "Advances in Application of Organic Additives for Perovskite Solar Cells: A Review"
2026 · Crossref
Author response for "Recent Advances in Carbohydrate Polymers-Supported Composites for Monitoring Breast Cancer Biomarkers: A Comprehensive Review"
2026 · Crossref
Author Index
Advances in Research on Pediatric Gender Affirming Healthcare · 2026 · Crossref
Author comment: Interventions to improve mental health help-seeking attitudes, intentions and behaviors: A systematic review of recent advances — R1/PR6
2026 · Crossref
Advances in clinical estimation of foetal weight before delivery
Nigerian Journal of Basic and Clinical Sciences · 2026 · Crossref
And 30 more candidates considered.